Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$428.58
-$1.78 (-0.41%)
Nov 2, 2026, 10:18 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.28B | 1.13B | 958.4M | 740.64M | 515.55M | 317.38M | 180.13M | 76.81M | 14.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 109.42M | 78.48M | 56.15M | 35.15M | 19.18M | 10.75M | 6.23M | 2.79M | 636K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.17B | 1.05B | 902.26M | 705.5M | 496.37M | 306.64M | 173.9M | 74.03M | 14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -322.62M | -313.51M | -300.1M | -307.48M | -309.81M | -425.15M | -497.87M | -548.05M | -530.28M | -454.2M | -380.5M | -348.62M | -330.5M | -314.32M | -293.57M | -272.87M | -255.62M | -247.09M | -242.48M | -237.44M | -233.06M | -221.65M |
Interest Income | 35.11M | 36.24M | 37.36M | 38.98M | 41.7M | 47.69M | 46.65M | 44.53M | 34.81M | 24.14M | 19.58M | 11.7M | 9.12M | 5.89M | 2.19M | 1.16M | 504K | 272K | 363K | 743K | 1.51M | 2.62M |
Pretax Income | -325.1M | -309.44M | -288.28M | -289.13M | -281.9M | -391.59M | -465.89M | -518.67M | -510.45M | -444.28M | -373.63M | -347.34M | -329.8M | -314.73M | -295.35M | -273.99M | -255.9M | -246.82M | -241.85M | -236.42M | -231.28M | -218.66M |
Net Income | -325.1M | -309.44M | -288.28M | -289.13M | -281.9M | -391.59M | -465.89M | -518.67M | -510.45M | -444.28M | -373.63M | -347.34M | -329.8M | -314.73M | -295.35M | -273.99M | -255.9M | -246.82M | -241.85M | -236.42M | -231.28M | -218.66M |
Selling & General & Admin | 1.01B | 914.47M | 813.83M | 715.07M | 613.54M | 522.13M | 435.06M | 340.37M | 260.37M | 172.76M | 108.15M | 76.17M | 60.73M | 54.65M | 48.13M | 45.29M | 41.43M | 39.77M | 37.32M | 31.73M | 28.94M | 24.47M |
Research & Development | 490.14M | 453.05M | 388.53M | 297.91M | 192.64M | 209.65M | 236.72M | 281.71M | 283.92M | 281.43M | 272.35M | 272.45M | 269.77M | 259.67M | 245.44M | 227.59M | 214.19M | 207.32M | 205.16M | 205.7M | 204.12M | 197.18M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.5B | 1.37B | 1.2B | 1.01B | 806.19M | 731.79M | 671.77M | 622.08M | 544.29M | 454.2M | 380.5M | 348.62M | 330.5M | 314.32M | 293.57M | 272.87M | 255.62M | 247.09M | 242.48M | 237.44M | 233.06M | 221.65M |
Interest Expense | 15.63M | 26.83M | 22.31M | 17.51M | 13.74M | 14.13M | 14.67M | 15.14M | 14.97M | 14.21M | 12.71M | 10.42M | 8.42M | 6.3M | 3.96M | 2.28M | 780K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.61B | 1.45B | 1.26B | 1.05B | 825.36M | 742.53M | 678.01M | 624.87M | 544.92M | 454.2M | 380.5M | 348.62M | 330.5M | 314.32M | 293.57M | 272.87M | 255.62M | 247.09M | 242.48M | 237.44M | 233.06M | 221.65M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 29.15M | 29.03M | 22.43M | 22.48M | 22.21M | 22.09M | 21.93M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
Shares Outstanding (Diluted) | 29.15M | 29.03M | 22.43M | 22.48M | 22.21M | 22.09M | 21.93M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
EPS (Basic) | -12.89 | -12.80 | -12.87 | -13.01 | -12.85 | -18.05 | -22.11 | -25.08 | -25.50 | -23.09 | -19.94 | -19.24 | -18.65 | -18.10 | -17.23 | -16.03 | -15.07 | -14.65 | -14.61 | -14.65 | -14.61 | -14.07 |
EPS (Diluted) | -12.89 | -12.80 | -12.87 | -13.01 | -12.85 | -18.05 | -22.11 | -25.08 | -25.50 | -23.09 | -19.94 | -19.24 | -18.65 | -18.10 | -17.23 | -16.03 | -15.07 | -14.65 | -14.61 | -14.65 | -14.61 | -14.07 |
EBITDA | -298.76M | -281.09M | -264.47M | -270.14M | -266.74M | -376.15M | -450.12M | -502.65M | -494.77M | -429.49M | -360.39M | -336.4M | -320.88M | -307.94M | -290.92M | -271.27M | -254.7M | -246.42M | -241.87M | -236.87M | -232.54M | -221.19M |
EBIT | -299.9M | -282.61M | -265.98M | -271.61M | -268.16M | -377.46M | -451.22M | -503.53M | -495.48M | -430.06M | -360.92M | -336.92M | -321.38M | -308.43M | -291.39M | -271.71M | -255.12M | -246.82M | -242.28M | -237.29M | -232.97M | -221.65M |
Depreciation & Amortization | 1.14M | 1.51M | 1.51M | 1.48M | 1.42M | 1.31M | 1.1M | 875K | 712K | 571K | 527K | 514K | 500K | 484K | 467K | 444K | 420K | 399K | 405K | 415K | 433K | 459K |
Add to Watchlist
Select watchlists to add or remove MDGL